MediFind found 7 doctor with experience in Peripheral T-Cell Lymphoma near Guangxi Zhuangzu Zizhiqu, CN. Of these, 6 are Experienced and 1 are Advanced.
Shu Zhao practices in Harbin, China. Zhao is rated as an Advanced expert by MediFind in the treatment of Peripheral T-Cell Lymphoma. Their top areas of expertise are Peripheral T-Cell Lymphoma, Non-Hodgkin Lymphoma, B-Cell Lymphoma, and T-Cell Lymphoma.
Hongxue Meng practices in Harbin, China. Meng is rated as an Experienced expert by MediFind in the treatment of Peripheral T-Cell Lymphoma. Their top areas of expertise are Throat Cancer, Laryngeal Cancer, IgA Nephropathy, Cerebral Hypoxia, and Laryngectomy.
Yupeng Liu practices in Harbin, China. Liu is rated as an Experienced expert by MediFind in the treatment of Peripheral T-Cell Lymphoma. Their top areas of expertise are Familial Wilms Tumor 2, Colorectal Cancer, Triple-Negative Breast Cancer, and Peripheral T-Cell Lymphoma.
Shuye Wang practices in Harbin, China. Wang is rated as an Experienced expert by MediFind in the treatment of Peripheral T-Cell Lymphoma. Their top areas of expertise are Acute Promyelocytic Leukemia, Peripheral T-Cell Lymphoma, Agranulocytosis, and Acute Myeloid Leukemia (AML).
Hongbin Li practices in Harbin, China. Li is rated as an Experienced expert by MediFind in the treatment of Peripheral T-Cell Lymphoma. Their top areas of expertise are Peripheral T-Cell Lymphoma, Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), and B-Cell Lymphoma.
Hongfei Ji practices in Harbin, China. Ji is rated as an Experienced expert by MediFind in the treatment of Peripheral T-Cell Lymphoma. Their top areas of expertise are Diffuse Large B-Cell Lymphoma (DLBCL), Breast Cancer, Inflammatory Breast Cancer, and Peripheral T-Cell Lymphoma.
Xibin Xiao practices in Jiefang, China. Xiao is rated as an Experienced expert by MediFind in the treatment of Peripheral T-Cell Lymphoma. Their top areas of expertise are Non-Hodgkin Lymphoma, B-Cell Lymphoma, Agranulocytosis, and T-Cell Lymphoma.
Last Updated: 10/30/2025